Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Grant/Award of 10,302 XNCR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Xencor Inc (XNCR) | Grant/Award | 10,302 | n/a |
| Jun 16, 2025 | Xencor Inc (XNCR) | Grant/Award | 13,686 | n/a |
| Mar 13, 2025 | Xencor Inc (XNCR) | Grant/Award | 43,337 | n/a |
| Jun 9, 2023 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 25,000 | n/a |
| May 16, 2022 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 25,000 | n/a |
| May 13, 2021 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 25,000 | n/a |
| May 7, 2020 | Neoleukin Therapeutics, Inc. (NLTX) | Grant/Award | 25,000 | n/a |